Work

Targeting BCL-2 overexpression in various human malignancies through NF-κB inhibition by the proteasome inhibitor bortezomib

Year: 2005

Type: article

Source: Cancer Chemotherapy and Pharmacology

DOI: 10.1007/s00280-004-0944-5

Authors: Bridget N. Fahy, Michael G. Schlieman, Melinda M. Mortenson, Subbulakshmi Virudachalam, Richard J. Bold

Institutions: University of California Davis Medical Center, UC Davis Comprehensive Cancer Center, University of California, Davis

Language: English

Topic: Cell death mechanisms and regulation

Subfield: Molecular Biology

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

Funder: American Cancer Society

OpenAlex ID: W2000143502

FWCI: 4.016

Cites: 46

Cited by: 125

Related to: 10